Clinical study on the efficacy and safety of Sakurajima Daikon on vascular endothelial function:an open randomized usual diet and Aokubi Daikon controlled three-sequence, three-phase crossover IIb study

Ohishi Mitsuru0 个研究点目标入组 21 人开始时间: 2022年3月30日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Patients with active or prior malignancy, heart failure, myocardial infarction.
•2) Patients undergoing treatment for the following chronic diseases(excluded hypertension, dyslipidemia and diabetes).
•Arrhythmia, Liver disorder*, Renal disorder*, Cerebrovascular disorder, Rheumatoid arthritis, and other chronic diseases.
•* The following definitions shall be used for Liver and Renal disorder.
•- Liver disorder: AST and ALT are more than 3 times the upper limit of the (facility) reference value.
•- Renal disorder: Serum creatine >= 2.4 mg/dL (men), >= 2.0 mg/dL (women).
•3) Patients with allergies (to medicines and test food related foods).
•4) Patients with pregnancy, on breast-feeding or who wish to become pregnant during trial.
•5) Current smoker in the 3 months prior to the date consent was obtained.
•6) Patients registered in other clinical trials presently or within 3 months before acquisition consent of this trial.
•7) Patients whom physician in charge considered inappropriate for the study.

发起方

Ohishi Mitsuru